PATENT CLAIM ANALYSIS

Application Number: 16134261
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["705", "002000"]

Abstract:
A glycemic control system includes a physician processor, remote processor, and a portable telephone having a data input mechanism, a display, and an internal processor for bi-directional communication with the physician's processor and the remote processor. A patient inputs data to the internal processor responsive to input from the physician's processor and then transmits the information to the remote processor where an optimized number of units to be administered is sent back and displayed on the portable telephone.

Claim (Index 12):
A system comprising:\n a user device controlled by a patient and having a screen, the user device configured to:\n execute a user interface for display on the screen; and \n receive, in the user interface displayed on the screen, an input from the patient for the current exercise parameter; and \n data processing hardware in communication with the user device, the data processing hardware configured to perform operations comprising:\n obtaining an insulin sensitivity factor for a patient and a target blood glucose range defined by upper and lower blood glucose limits for the patient from memory hardware in communication with the data processing hardware; \n receiving a current blood glucose measurement of the patient and the current exercise parameter for the patient during a time period of the current blood glucose measurement from the user device; \n determining whether the current blood glucose measurement is less than the midpoint of the target blood glucose range for the patient; \n when the current blood glucose measurement is less than the midpoint of the target blood glucose range for the patient:\n determining carbohydrate intake instructions including a predetermined number of carbohydrates for the patient to ingest based on the exercise parameter; and \n transmitting the carbohydrate intake instructions to the user device, the carbohydrate intake instructions when received by the user device, causing the user interface executing on the user device to display the predetermined number of carbohydrates for the patient to ingest; and \n \n when the current blood glucose measurement exceeds the midpoint of the target blood glucose range for the patient:\n determining a correction dose based on a function of the current blood glucose measurement, the midpoint of the target blood glucose range and the insulin sensitivity factor; and \n transmitting the correction dose from the data processing hardware to the user device, the correction dose, when received by the user device, causing the user interface executing on the user device to display the correction dose.

Metadata:
- Claim Count in Document: 56.0
- Percentile: 97.0
- Lexical Diversity: 1.82979
- Patent Class: 705.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15677397', '15403880', '14861427', '15943900', '15283838']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.2113094405656884
- 35 USC 102 Novelty (BERT): 0.6425104467105776
- Combined Prediction Score: 0.2544295411801773
- Mean Citation Score: 610.1142520000002
- Max Citation Score: 640.9923
- Similarity Product: 598.3159129838705

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test